L&C Bio Co. Ltd Cash Flow-to-Debt Ratio
L&C Bio Co. Ltd cash flow-to-debt ratio. L&C Bio Co. Ltd (290650) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of ₩3.79 Billion could theoretically repay 0% of its total liabilities (₩231.24 Billion) in one year. Check total reinvestment intensity of L&C Bio Co. Ltd to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of L&C Bio Co. Ltd (2015–2024)
Cash flow-to-debt ratio of L&C Bio Co. Ltd from 2015 to 2024. Historical debt coverage capacity for L&C Bio Co. Ltd across 10 annual periods. Check how high is L&C Bio Co. Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
L&C Bio Co. Ltd Cash Flow-to-Debt Ratio by Year (2015–2024)
L&C Bio Co. Ltd cash flow-to-debt ratio by year from 2015 to 2024. Year-by-year debt coverage analysis for L&C Bio Co. Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of L&C Bio Co. Ltd.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.04x | ₩-8.57 Billion | ₩191.25 Billion | ▲ +57.4% |
| 2023 | -0.11x | ₩-12.13 Billion | ₩115.29 Billion | ▼ -76.3% |
| 2022 | -0.06x | ₩-6.08 Billion | ₩101.77 Billion | ▼ -112.3% |
| 2021 | 0.49x | ₩10.91 Billion | ₩22.38 Billion | ▲ +49.6% |
| 2020 | 0.33x | ₩7.42 Billion | ₩22.77 Billion | ▼ -59.2% |
| 2019 | 0.80x | ₩6.43 Billion | ₩8.04 Billion | ▲ +2.2% |
| 2018 | 0.78x | ₩3.85 Billion | ₩4.92 Billion | ▼ -24.7% |
| 2017 | 1.04x | ₩3.82 Billion | ₩3.68 Billion | ▲ +3259.6% |
| 2016 | -0.03x | ₩-185.35 Million | ₩5.64 Billion | ▲ +87.1% |
| 2015 | -0.26x | ₩-1.33 Billion | ₩5.20 Billion | — |